123 related articles for article (PubMed ID: 35355274)
1. In silico analysis and experimental validation to exhibit anti-nasopharyngeal carcinoma effects of plumbagin, an anti-cancer compound.
Liang X; Pan Q; Liao Y; Nie L; Yang L; Liu F; Su M
J Sci Food Agric; 2022 Sep; 102(12):5460-5467. PubMed ID: 35355274
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
[TBL] [Abstract][Full Text] [Related]
3. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
4. Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking.
Fan JY; Liu J; Zhang WQ; Lin T; Hu XR; Zhou FL; Tang L; He YC; Shi HJ
Medicine (Baltimore); 2023 Dec; 102(48):e36477. PubMed ID: 38050231
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Molecular Mechanism of
Xu R; Yang X; Tao Y; Luo W; Xiong Y; He L; Zhou F; He Y
J Healthc Eng; 2022; 2022():6277139. PubMed ID: 35463684
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the mechanism of Yiqi Jiedu formula against nasopharyngeal carcinoma: An investigation integrating network pharmacology, serum pharmacochemistry, and metabolomics.
Zhou F; Wang W; Xu R; Liu L; Lin T; He L; Tang L; Wang X; He Y
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117343. PubMed ID: 37879509
[TBL] [Abstract][Full Text] [Related]
9. Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin.
Li Y; Yu S; Li Y; Liang X; Su M; Li R
Front Endocrinol (Lausanne); 2021; 12():714909. PubMed ID: 34712201
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.
Wang J; Wu J; Li X; Liu H; Qin J; Bai Z; Chi B; Chen X
J Proteomics; 2018 Jun; 182():1-11. PubMed ID: 29684682
[TBL] [Abstract][Full Text] [Related]
11. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
12. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
13. [Key Prediction Genes of Nasopharyngeal Carcinoma:Screening Based on Systematic Bioinformatics and Validation by Cell Experiments].
Huang ZK; Li F; Chen YZ; Liu JM; Liu JJ; Lan SZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Aug; 45(4):597-607. PubMed ID: 37654140
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations.
Ling J; Huang Y; Sun Z; Guo X; Chang A; Pan J; Zhuo X
Front Pharmacol; 2022; 13():996728. PubMed ID: 36506508
[No Abstract] [Full Text] [Related]
15. Network Pharmacology to Uncover the Molecular Mechanisms of Action of LeiGongTeng for the Treatment of Nasopharyngeal Carcinoma.
Mi JL; Liu C; Xu M; Wang RS
Med Sci Monit Basic Res; 2020 May; 26():e923431. PubMed ID: 32448862
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Plumbagin on Pancreatic Cancer: A Mechanistic Network Pharmacology Approach.
Pan Q; Zhou R; Su M; Li R
Med Sci Monit; 2019 Jun; 25():4648-4654. PubMed ID: 31230062
[TBL] [Abstract][Full Text] [Related]
17. The Highly Expressed IFIT1 in Nasopharyngeal Carcinoma Enhances Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Wu X; Lin L; Zhou F; Yu S; Chen M; Wang S
Mol Biotechnol; 2022 Jun; 64(6):621-636. PubMed ID: 35038119
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.
Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY
Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377
[TBL] [Abstract][Full Text] [Related]
19. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
20. Bioinformatics Analysis of the Signaling Pathways and Genes of Gossypol Induce Death of Nasopharyngeal Carcinoma Cells.
Zhu K; Ge J; He Y; Li P; Jiang X; Wang J; Mo Y; Huang W; Gong Z; Zeng Z; Xiong W; Yu J
DNA Cell Biol; 2021 Aug; 40(8):1052-1063. PubMed ID: 34191589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
